A bumpy road to breakthroughs. The news: it's hard to beat today's cardiac treatments.
D000818:Animals; D050197:Atherosclerosis / Q000000981:diagnostic imaging / Q000188:drug therapy*; D003328:Coronary Thrombosis / Q000150:complications / Q000188:drug therapy; D003924:Diabetes Mellitus, Type 2 / Q000188:drug therapy*; D026690:Ethics, Clinical; D005998:Glycine / Q000009:adverse effects / Q000031:analogs & derivatives*; D006333:Heart Failure / Q000628:therapy*; D006801:Humans; D007210:Indoleacetic Acids / Q000627:therapeutic use*; D009203:Myocardial Infarction / Q000139:chemically induced / Q000209:etiology; D010080:Oxazoles / Q000009:adverse effects*; D019736:Prostheses and Implants; D020521:Stroke / Q000139:chemically induced; D017211:Treatment Failure; D014463:Ultrasonography
D007210:Indoleacetic Acids; D010080:Oxazoles; C509302:pactimibe; D005998:Glycine; C500085:muraglitazar